Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

173896 ARTíCULOS , VIENDO DEL 172666 AL 172680

PUBMED

The early diagnosis of Parkinson's disease through combined biomarkers.

Chen XQ, Niu JP, Peng RQ, Song YH, Xu N, Zhang YW.

Acta Neurol Scand. 2019 Oct;140(4):268-273. doi: 10.1111/ane.13140. Epub 2019 Jun 13.

0

0

0

PUBMED

Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.

Dixit A, Mehta R, Singh AK.

Cell Mol Neurobiol. 2019 Oct;39(7):901-915. doi: 10.1007/s10571-019-00700-9. Epub 2019 Jun 12. Review.

0

0

0

PUBMED

Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor/α-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling.

Li B, Jiang Y, Xu Y, Li Y, Li B.

Chemosphere. 2019 Oct;233:542-548. doi: 10.1016/j.chemosphere.2019.05.064. Epub 2019 May 23.

0

0

0

PUBMED

Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.

Black KJ, Nasrallah H, Isaacson S, Stacy M, Pahwa R, Adler CH, Alva G, Cooney JW, Kremens D, Menza MA, Meyer JM, Patkar AA, Simuni T, Morrissette DA, Stahl SM.

CNS Spectr. 2019 Oct;24(5):574-575. doi: 10.1017/S1092852919000932. No abstract available.

0

0

0

PUBMED

Invasive and Noninvasive Brain Stimulation in Parkinson's Disease: Clinical Effects and Future Perspectives.

Chen KS, Chen R.

Clin Pharmacol Ther. 2019 Oct;106(4):763-775. doi: 10.1002/cpt.1542. Epub 2019 Jul 22. Review.

0

0

0

PUBMED

Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.

Specketer K, Zabetian CP, Edwards KL, Tian L, Quinn JF, Peterson-Hiller AL, Chung KA, Hu SC, Montine TJ, Cholerton BA.

J Clin Exp Neuropsychol. 2019 Oct;41(8):803-813. doi: 10.1080/13803395.2019.1623180. Epub 2019 Jun 10.

0

0

0

PUBMED

How do Parkinson's disease patients manage Ramadan fasting? An observational study.

Kamel WA, Al Hashel JY, Damier P.

Rev Neurol (Paris). 2019 Oct;175(9):560-563. doi: 10.1016/j.neurol.2018.12.008. Epub 2019 Jun 5.

0

0

0

PUBMED

A secret that underlies Parkinson's disease: The damaging cycle.

Sun F, Deng Y, Han X, Liu Q, Zhang P, Manzoor R, Ma H.

Neurochem Int. 2019 Oct;129:104484. doi: 10.1016/j.neuint.2019.104484. Epub 2019 Jun 4. Review.

0

0

0

PUBMED

A different view on the pathophysiology of Parkinson's disease: a descendent neurochemical hypothesis?

Yulug B, Ozansoy M, Cankaya S.

Neural Regen Res. 2019 Oct;14(10):1717-1718. doi: 10.4103/1673-5374.257527. No abstract available.

0

0

0

PUBMED

The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson's disease.

Russo I.

Neural Regen Res. 2019 Oct;14(10):1713-1714. doi: 10.4103/1673-5374.257523. No abstract available.

0

0

0

PUBMED

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.

Wegrzynowicz M, Bar-On D, Calo' L, Anichtchik O, Iovino M, Xia J, Ryazanov S, Leonov A, Giese A, Dalley JW, Griesinger C, Ashery U, Spillantini MG.

Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.

0

0

0

PUBMED

Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics.

Deb S, Dutta A, Phukan BC, Manivasagam T, Justin Thenmozhi A, Bhattacharya P, Paul R, Borah A.

Neurochem Int. 2019 Oct;129:104478. doi: 10.1016/j.neuint.2019.104478. Epub 2019 May 27. Review.

0

0

0

PUBMED

Effects of Parkinson's disease on molar bite force, electromyographic activity and muscle thickness of the masseter, temporal and sternocleidomastoid muscles: A case-control study.

Donizetti Verri E, da Silva GP, Marianetti Fioco E, Soares da Silva N, Valin Fabrin SC, Augusto Bueno Zanella C, Roberta Garrefa C, Faria Júnior M, Siéssere S, Hallak JEC, Palinkas M, Chaves TC, Regal

J Oral Rehabil. 2019 Oct;46(10):912-919. doi: 10.1111/joor.12824. Epub 2019 Jun 17.

0

0

0

PUBMED

Emotional valence may influence memory performance for visual artworks in Parkinson's disease.

Ciccarelli N, Di Tella S, Lo Monaco MR, Carfì A, Serafini E, Delle Donne V, Silveri MC.

Neurol Sci. 2019 Oct;40(10):2175-2178. doi: 10.1007/s10072-019-03939-8. Epub 2019 May 29.

0

0

0

PUBMED

Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety.

Vieira JCF, Bassani TB, Santiago RM, de O Guaita G, Zanoveli JM, da Cunha C, Vital MABF.

Behav Brain Res. 2019 Oct 3;371:111981. doi: 10.1016/j.bbr.2019.111981. Epub 2019 May 26.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy